Welcome to our dedicated page for Irhythm Technologies SEC filings (Ticker: IRTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SEC documents from iRhythm Technologies don’t just recount earnings—they weave together reimbursement rulings, FDA study updates, and device-level production metrics that can shift Zio patch economics overnight. For investors, pulling the one sentence about CMS pricing from a 250-page 10-K or tracking day-to-day insider sales feels daunting.
Stock Titan solves that complexity. Our AI reads every iRhythm quarterly earnings report 10-Q filing, each iRhythm 8-K material event, and flags changes in plain English. Want iRhythm insider trading Form 4 transactions within minutes? You’ll see alerts the moment the Form 4 hits EDGAR, complete with contextual charts. Need an iRhythm annual report 10-K simplified or a quick iRhythm earnings report filing analysis? Our summaries spotlight Zio XT volume, average selling price shifts, and R&D spend so you can focus on decisions instead of footnotes.
Common investor questions are answered up front:
- iRhythm Form 4 insider transactions real-time
- iRhythm proxy statement executive compensation details
- understanding iRhythm SEC documents with AI
Beyond speed, our platform ties each disclosure to what truly moves the stock: hospital adoption rates, Medicare billing codes, and manufacturing scale. Drill into an iRhythm executive stock transactions Form 4 to see how trades align with new Zio AT rollouts, or compare segment margins across quarters without combing through PDFs. With real-time updates, complete filing coverage, and AI-powered plain-language explanations, iRhythm SEC filings explained simply becomes more than a promise—it’s the workflow that lets you act before the market does.
Form 144 summary: Form 144 notifies a proposed sale of 30,000 common shares through Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004) on NASDAQ, approximate sale date 08/05/2025. Aggregate market value is reported as $4,816,190.87 and shares outstanding are reported as 32,127,763.
Acquisition history and disclosures: The form lists three acquisitions that total 30,000 shares—restricted stock 11/01/2023: 7,449; open-market purchase 06/06/2023: 9,755 (paid cash); restricted stock 11/01/2022: 12,796. The form states "Nothing to Report" for securities sold during the past three months. Several identification fields (filer CIK, issuer name, date of notice, signature) are blank in the provided content.
FAQ
What is the current stock price of Irhythm Technologies (IRTC)?
What is the market cap of Irhythm Technologies (IRTC)?
